{"id":27,"date":"2004-08-18T21:21:59","date_gmt":"2004-08-18T12:21:59","guid":{"rendered":"http:\/\/haruko.km2m.net\/2004\/08\/18\/bexxer%e3%81%a8zevalin%e6%af%94%e8%bc%83\/"},"modified":"2004-08-18T21:21:59","modified_gmt":"2004-08-18T12:21:59","slug":"bexxer%e3%81%a8zevalin%e6%af%94%e8%bc%83","status":"publish","type":"post","link":"https:\/\/haruko.km2m.net\/?p=27","title":{"rendered":"Bexxer\u3068Zevalin\u6bd4\u8f03"},"content":{"rendered":"<p>Bexxer\u3068Zevalin\u6bd4\u8f03<\/p>\n<p>Lymphomation Org<br \/>\nhttp:\/\/www.lymphomation.org\/compare-bexxar-zevalin.htm<\/p>\n<p>2004\/8\/18<br \/>\n\u60a3\u8005\u306f\u3057\u3070\u3057\u3070\u3053\u3046\u5c0b\u306d\u307e\u3059\u3002\u300c\u3069\u3061\u3089\u306e\u6cbb\u7642\u85ac\u306e\u307b\u3046\u304c\u3044\u3044\u306e\u3067\u3059\u304b?\u300d<br \/>\n\u3053\u308c\u3089\u306e\u6cbb\u7642\u85ac\u306f\u76f4\u63a5\u5bfe\u6c7a\u3067\u6bd4\u8f03\u7814\u7a76\u306f\u884c\u308f\u308c\u3066\u3044\u307e\u305b\u3093\u3002\u3057\u305f\u304c\u3063\u3066\u3001\u308f\u308c\u308f\u308c\u306f\u78ba\u4fe1\u3092\u6301\u3063\u3066\u3069\u3061\u3089\u304c\u3044\u3044\u304b\u3092\u8ff0\u3079\u308b\u3053\u3068\u306f\u3067\u304d\u307e\u305b\u3093\u3002<br \/>\n\u304a\u305d\u3089\u304f\u3001\u3053\u308c\u3089\u306e\u6cbb\u7642\u85ac\u306e\u7279\u6027\u3092\u5217\u6319\u3057\u3001\u500b\u4eba\u306e\u6cbb\u7642\u74b0\u5883\u306b\u5408\u3063\u305f\u9078\u629e\u80a2\u3092\u5c02\u9580\u533b\u306b\u5c0b\u306d\u308b\u3053\u3068\u304c\u5f79\u306b\u7acb\u3064\u3067\u3057\u3087\u3046\u3002<br \/>\n\u3053\u308c\u3089\u306e\u6cbb\u7642\u85ac\u306f\u6bd4\u8f03\u7684\u65b0\u3057\u3044\u306e\u3067\u3001\u5730\u57df\u306e\u816b\u760d\u533b\u3089\u306f\u4e21\u8005\u306e\u76f8\u9055\u70b9\u3092\u8a73\u3057\u304f\u691c\u7d22\u3059\u308b\u6642\u9593\u306f\u53d6\u308c\u3066\u3044\u306a\u3044\u304b\u3082\u3057\u308c\u307e\u305b\u3093\u3002<\/p>\n<p>\u7279\u6027<\/p>\n<p>Bexxar<br \/>\n\uff08tositumomab\uff09<\/p>\n<p>Zevalin<br \/>\n\uff08Ibritumomab tiuxetan)<\/p>\n<p>\n\u25a0 \u6297\u4f53<br \/>\n\u30de\u30a6\u30b9<br \/>\nanti-CD20\u3000\u6297\u4f53<\/p>\n<p>\u30de\u30a6\u30b9<br \/>\nanti-CD20\u3000\u6297\u4f53<\/p>\n<p>\n\u25a0 FDA\u627f\u8a8d\u9069\u5fdc\u306e\u57fa\u6e96<br \/>\n\u30ea\u30c4\u30ad\u30b7\u30de\u30d6\u306b\u62b5\u6297\u6027\u306b\u306a\u3063\u305f\u3001\u5316\u5b66\u7642\u6cd5\u5f8c\u518d\u767a\u306e\u3001CD20\u967d\u6027\u306e\u6ffe\u80de\u6027\u975e\u30db\u30b8\u30ad\u30f3\u30ea\u30f3\u30d1\u816b\uff08NHL\uff09\u60a3\u8005\u3078\u306e\u6cbb\u7642\u3002\u8ee2\u63db\u306e\u3042\u308b\u306a\u3057\u3092\u554f\u308f\u306a\u3044 Bexxar.com<\/p>\n<p>\u518d\u767a\u6027\u307e\u305f\u306f\u96e3\u6cbb\u6027\u306e\u4f4e\u60aa\u6027\u5ea6\u3001\u6ffe\u80de\u6027\u307e\u305f\u306f\u8ee2\u63db\u3057\u305fB\u7d30\u80de\u6027\u975e\u30db\u30b8\u30ad\u30f3\u30ea\u30f3\u30d1\u816b\u3002\u3053\u306e\u9069\u5fdc\u306f\u30ea\u30c4\u30ad\u30b5\u30f3Rituxan (rituximab)\u306b\u96e3\u6cbb\u6027\u6ffe\u80de\u6027NHL\u3092\u542b\u3080\u3002Zevalin\u306f\u3001\u30ea\u30c4\u30ad\u30b5\u30f3\u6cbb\u7642\u3092\u542b\u3080\u3082\u306e\u3068\u3057\u3066\u627f\u8a8d\u3055\u308c\u305f\u3002Zevalin.com<\/p>\n<p>\n\u25a0 \u60a3\u8005\u4e00\u4eba\u5f53\u305f\u308a\u306e\u30b3\u30b9\u30c8<br \/>\n\u3053\u306e\u6bd4\u8f03\u306f\u5225\u306e\u30bd\u30fc\u30b9\u304b\u3089\u306e\u5927\u307e\u304b\u306a\u898b\u7a4d\u3082\u308a\u3067\u3042\u308b\u3002\u3000\u3000\u3000\u3000\u3000\u3000\uff08\u7565\uff09<\/p>\n<p>\n\u6295\u4e0e\u91cf\u6c7a\u5b9a<\/p>\n<p>\u7dda\u91cf\u6e2c\u5b9a<br \/>\n\u56fa\u5b9a\u91cf\uff1f\u307e\u305f\u306f\u4f53\u91cd\u3068\u6cbb\u7642\u524d\u8840\u5c0f\u677f\u5024<\/p>\n<p>\u6295\u4e0e\u91cf\/\u79fb\u52d5-\u6b63\u5e38\u7d30\u80de\u3078\u306e\u653e\u5c04\u7dda\u5438\u53ce\u91cf<\/p>\n<p>\u7532\u72b6\u817a\u3078<br \/>\n\u809d\u81d3\u3078\uff08\u809d\u81d3\uff1a\u4f53\u5168\u4f53\u30ec\u30b7\u30aa\u306f8:1\u3067\u3042\u308b\u3002\u809d\u81d3\u3078\u306e\u6295\u85ac\u91cf\u306f900cGy\u3068\u898b\u7a4d\u3082\u3089\u308c\u308b\u3053\u3068\u306b\u6ce8\u610f\uff09<\/p>\n<p>\n\u88f8\u6297\u4f53\u306e\u524d\u6295\u4e0e<\/p>\n<p>\n\u3042\u308a<\/p>\n<p>\u3042\u308a<\/p>\n<p>\u30e9\u30b8\u30aa\u30a2\u30a4\u30bd\u30c8\u30fc\u30d7\uff0d\u653e\u5c04\u7269<\/p>\n<p>Iodine131<br \/>\n\u30ac\u30f3\u30de\u7dda\u3068\u30d9\u30fc\u30bf\u7dda\u3092\u653e\u5c04<\/p>\n<p>Ytrium 90<br \/>\n\u30d9\u30fc\u30bf\u7dda\u3092\u653e\u5c04<\/p>\n<p>\u30e9\u30b8\u30aa\u30a2\u30a4\u30bd\u30c8\u30fc\u30d7\uff0d\u30af\u30ea\u30a2\u30e9\u30f3\u30b9<\/p>\n<p>\u901f\u3044<\/p>\n<p>\u9045\u3044<\/p>\n<p>\u30e9\u30b8\u30aa\u30a2\u30a4\u30bd\u30c8\u30fc\u30d7\uff0d\u534a\u6e1b\u671f<\/p>\n<p>8\u65e5<\/p>\n<p>\uff082.7\u65e5\uff09<\/p>\n<p>\u30e9\u30b8\u30aa\u30a2\u30a4\u30bd\u30c8\u30fc\u30d7\uff0d\u6ce2\u9577<\/p>\n<p>\u77ed\u3044<\/p>\n<p>\u9577\u3044<\/p>\n<p>\n\u6a19\u7684<\/p>\n<p>\u6210\u719fB-cell\u306eCD20\u53d7\u5bb9\u4f53<\/p>\n<p>\u6210\u719fB-cell\u306eCD20\u53d7\u5bb9\u4f53<\/p>\n<p>\u91ce\u4e2d\u3000\u5e0c\u3000\u3000\u8a33<br \/>\nDr. Saru \u3000\u76e3\u4fee<\/p>\n<p>http:\/\/www.cancerit.jp\/archive37Bexxar.html#2bvz<br \/>\n\u3000\u3000<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bexxer\u3068Zevalin\u6bd4\u8f03 Lymphomation Org http:\/\/www.lymphomation.org\/compare-bexxar-zevalin.htm 2004\/8\/18 \u60a3\u8005\u306f\u3057\u3070\u3057\u3070\u3053\u3046\u5c0b\u306d &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/haruko.km2m.net\/?p=27\" class=\"more-link\"><span class=\"screen-reader-text\">&#8220;Bexxer\u3068Zevalin\u6bd4\u8f03&#8221; \u306e<\/span>\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-27","post","type-post","status-publish","format-standard","hentry","category-4"],"_links":{"self":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/posts\/27","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=27"}],"version-history":[{"count":0,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/posts\/27\/revisions"}],"wp:attachment":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=27"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=27"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=27"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}